Day: August 26, 2022

Oslo, 26 August 2022 – DNO ASA, the Norwegian oil and gas operator, today confirmed an oil discovery on the Ofelia prospect in the Norwegian North Sea license PL929 in which the Company holds a 10 percent interest. The well encountered a 73-meter oil column in Lower Cretaceous Agat Formation sandstones of moderate to good reservoir quality. Preliminary estimates of gross recoverable resources are in the range of 16-39 million barrels of oil equivalent. In addition, upsides have been identified in both the Agat Formation and the overlying Kyrre Formation. The partners, which in addition to the Company’s wholly-owned subsidiary DNO Norge AS, include license operator Neptune Energy Norge AS, Wintershall Dea Norge AS, Pandion Energy AS and ABP Norway AS, will consider development of the discovery with a tieback to the Neptune-operated Gjøa...

The board of directors (the “Board“) of AKVA group ASA (“AKVA” or the “Company“) has resolved to implement a revised incentive plan (the “Incentive Plan“) for senior management of AKVA. The overall purpose of the revised Incentive Plan is to ensure aligned interest between senior management employees and shareholders in the current business environment, and to reward long-term and dedicated work, which is deemed to be of value to AKVA and its shareholders. The Incentive Plan replaces the Company’s existing share-based incentive plan for the period 2020-2026. The Incentive Plan participants have agreed that no payments or allocations will be made under the previous incentive plan in exchange for their participation in the revised Incentive Plan. Furthermore, the Board has resolved to...

Date: 26 August 2022 Release: Before opening of Euronext Please open the following link to read the full report including annexes:AttachmentFULL PRESS RELEASE

REGULATED INFORMATION Preliminary documents for the Extraordinary General Meeting have been made available on company’s website Mont-Saint-Guibert, Belgium, 26 August 2022, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the cell therapy company addressing unmet medical needs in orthopedics, invites its shareholders and the holders of registered subscription rights and registered convertible bonds of the Company to the extraordinary general meeting to be held on Monday 26 September 2022 as from 05:00 pm CEST, at Avenue Lloyd George 11, 1000 Brussels, Belgium. The notice for the extraordinary general meeting, including the agenda of the day as well as the motions to vote, is published today in the Belgian Official Gazette and La Libre Belgique. The documents and preliminary information concerning the extraordinary general...

Louvain-La-Neuve, Belgium, 26 August, 2022 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces that the Company is the only proton therapy equipment supplier that has qualified for the second round of a significant public tender launched by the Spanish Ministry of Health. This public tender is aimed at selecting one or several proton therapy suppliers to install 10 proton therapy units across the country. The Spanish Ministry of Health has published the results of the first round of selection of the proton therapy public tender with IBA being the only vendor fulfilling all the criteria. Therefore, IBA has qualified for the second round, with three rounds in total. In 2021, the Ministry...